Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, scPharmaceuticals (SCPH) has a market cap of $0.16 billion USD. According to our data, scPharmaceuticals is ranked No.7311 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.16 B |
-9.32%
|
| Dec 31, 2024 | $0.18 B |
-43.54%
|
| Dec 29, 2023 | $0.31 B |
-12.55%
|
| Dec 30, 2022 | $0.36 B |
42.83%
|
| Dec 31, 2021 | $0.25 B |
-5.10%
|
| Dec 31, 2020 | $0.26 B |
-6.54%
|
| Dec 31, 2019 | $0.28 B |
50.53%
|
| Dec 31, 2018 | $0.19 B |
-68.90%
|
| Dec 29, 2017 | $0.60 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
 Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
 United Therapeutics
UTHR
|
$16.58 B |
-0.000 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
 Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
 Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
 BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
 Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
| Market Cap | = | SCPH Stock Price | * | SCPH Shares Outstanding |
| = | $3.21 | * | 50.04 M | |
| = | $0.16 B |